Arabio vaccinates 79% of adults in Saudi Arabia

Arabio focused on covering 79% of adult vaccinations in Saudi Arabia and is working towards full localization of the entire vaccine value chain within the Kingdom. It is currently beginning initial manufacturing stages, such as secondary packaging, and has plans for a gradual transition to more advanced manufacturing phases to enhance supply independence and reduce dependence on imports. The company has secured around 70 million doses over recent years, exporting parts of its products to Gulf countries, the Levant, and North Africa. It aims to expand its regional market share with investments of up to half a billion riyals over the next 20 years.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل